Takeaways from this week in optometry: March 10 - March 14

Blog
Slideshow

Catch up on the top stories in optometry during the week of March 10-March 14.

slideshow image

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

The FDA has accepted the New Drug Application (NDA) submitted by Sydnexis for SYD-101, a low-dose atropine drop indicated for myopia management, with a Prescription Drug User Fee Act (PDUFA) target action date set for October 23, 2025. If approved, the atropine drop will be the first and only pharmaceutical option for the treatment of progression of pediatric myopia in the United States.

Recent Videos
SECO 2025: Insightful discussions on light therapy, ptosis, and the view from behind the slit lamp
SECO 2025: Insightful discussions on light therapy, ptosis, and the view from behind the slit lamp
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
What optometrists gained from attending SECO 2025
The California Optometric Association and the Los Angeles County Optometric Society have compiled resources for optometrists to get involved in continuing relief efforts.
How ODs are helping with Los Angeles wildfire cleanup
Dr. Stephanie Woo discusses the upcoming CRU Eye Symposium
CRU 2025: Sipping fine wine and sharpening minds
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
What patients should know about eye protection during natural disasters
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Eye care organizations, practices provide vision care amid the Greater Los Angeles wildfires
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
SECO 2025: Tackling myopia management while patients are young
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
SECO 2025: Exploring the latest in anterior segment technology and laser treatments
Dr. Ben Casella highlights the importance of SECO to the optometric community.
SECO 2025: Where optometry meets innovation and community
Dr. Mile Brujic discusses a case series on a novel gel for lacrimal occlusion.
SECO 2025: A novel gel may work better than punctal plugs for lacrimal occlusion
Related Content
Graphic of stock market and coins Image credit: AdobeStock/Kiattisak

BVI Medical completes a $1 billion strategic capital raise

Jordana Joy, Associate Editor
March 14th 2025
Article
New Opportunities in Topical Glaucoma Management

New Opportunities in Topical Glaucoma Management

Mitch Ibach, OD, FAAO;Jessica Steen, OD, FAAO
January 31st 2025
Podcast
Physician consoling patient with eye pain Image credit: AdobeStock/StudioRomantic

New patient survey unveils dissatisfaction with glaucoma treatment

Jordana Joy, Associate Editor
March 14th 2025
Article
You and Eye: Vision training research in eSports - with Tiffany Tsoi, OD, FAAO

You and Eye: Vision training research in eSports - with Tiffany Tsoi, OD, FAAO

Miriam Korik, OD;Tiffany Tsoi, OD;Emily Kaiser Maharjan, Assistant Managing Editor
December 4th 2024
Podcast
Eye drop containers Image credit: AdobeStock/DavizroPhotography

Cyclosporine A eye drops ease ocular discomfort after cataract surgery, study finds

Lynda Charters
March 13th 2025
Article
The formulation of presbyopia-correcting drops makes a difference is comfort and usability - Image credit: Adobe Stock / ©Andrey Nikitin

The science of formulation: Advancing presbyopia treatment through optimized design

Jacob R. Lang, OD, FAAO;Jaclyn Garlich, OD, FAAO
March 13th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.